EcoDrugPlus

Ensembl ID : ENSPKIG00000021515
Gene Symbol: -
Cross references: -
109 Possible Orthologues:

Ensembl ID : ENSPKIG00000011343
Gene Symbol: -
Cross references: -
77 Possible Orthologues:

Ensembl ID : ENSPKIG00000023564
Gene Symbol: -
Cross references: -
247 Possible Orthologues:

Ensembl ID : ENSPKIG00000011417
Gene Symbol: -
1 Cross references
198 Possible Orthologues:

Ensembl ID : ENSPKIG00000013890
Gene Symbol: -
Cross references: -
102 Possible Orthologues:

Ensembl ID : ENSPKIG00000014711
Gene Symbol: -
Cross references: -
11 Possible Orthologues:

Ensembl ID : ENSPKIG00000011471
Gene Symbol: -
Cross references: -
148 Possible Orthologues:

Ensembl ID : ENSPKIG00000010558
Gene Symbol: RPS15A
2 Cross references
79 Possible Orthologues:

Ensembl ID : ENSPKIG00000019661
Gene Symbol: -
Cross references: -
78 Possible Orthologues:

Ensembl ID : ENSPKIG00000017161
Gene Symbol: -
Cross references: -
62 Possible Orthologues:

Ensembl ID : ENSPKIG00000001071
Gene Symbol: -
Cross references: -
239 Possible Orthologues:

Ensembl ID : ENSPKIG00000008537
Gene Symbol: -
Cross references: -
103 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).